Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.38 |
| ▸ | GGT1 | P19440 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL867866 | 0.87 | ALDH1A1 (0.48) | ALDH1A1ALOX15CYP3A4KMT2AAKR1C3 | |
| SCHEMBL10581907 | 0.83 | ALDH1A1 (0.44) | ALDH1A1ALOX15CYP3A4KMT2AAKR1C3 | |
| SCHEMBL828388 | 0.81 | ALDH1A1 (0.54) | ALDH1A1ALOX15AKR1C3KDM4EHSD17B10 | |
| SCHEMBL867865 | 0.81 | CYP3A4 (0.47) | ALDH1A1ALOX15CYP3A4HSD17B10TSHR | |
| SCHEMBL27710480 | 0.79 | ALDH1A1 (0.44) | ALDH1A1ALOX15CYP3A4KMT2AAKR1C3 | |
| SCHEMBL28331298 | 0.79 | ALDH1A1 (0.45) | ALDH1A1ALOX15CYP3A4KMT2AKDM4E | |
| SCHEMBL30339401 | 0.79 | ALDH1A1 (0.56) | ALDH1A1ALOX15AKR1C3KDM4EHSD17B10 | |
| SCHEMBL722115 | 0.79 | ALDH1A1 (0.56) | ALDH1A1ALOX15AKR1C3KDM4EHSD17B10 | |
| SCHEMBL7196758 | 0.78 | ALDH1A1 (0.42) | ALDH1A1ALOX15CYP3A4KMT2AAKR1C3 | |
| Water SCHEMBL28274877 | 0.78 | ALDH1A1 (0.54) | ALDH1A1ALOX15AKR1C3KDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2542223-B1 | COMPLEX FORMULATION FOR ORAL ADMINISTRATION COMPRISING PROBIOTIC FORMULATION AND 5-HT4 RECEPTOR AGONIST AND METHOD FOR THE PREPARATION THEREOF | HANMI SCIENCE CO LTD (KR) | 2015-09-23 | — | — | EP | claimed |
| EP-2542223-A2 | COMPLEX FORMULATION FOR ORAL ADMINISTRATION COMPRISING PROBIOTIC FORMULATION AND 5-HT4 RECEPTOR AGONIST AND METHOD FOR THE PREPARATION THEREOF | Hanmi Science Co., Ltd. (KR) | 2013-01-09 | — | — | EP | claimed |
| US-20120321709-A1 | COMPLEX FORMULATION FOR ORAL ADMINISTRATION COMPRISING PROBIOTIC FORMULATION AND 5-HT4 RECEPTOR AGONIST AND METHOD FOR THE PREPARATION THEREOF | HANMI SCIENCE CO LTD (KR) | 2012-12-20 | — | — | US | claimed |
| US-20120015032-A1 | COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME | HANALL PHARMACEUTICAL COMPANY, LTD. (KR) | 2012-01-19 | — | — | US | claimed |
| WO-2011108826-A2 | COMPLEX FORMULATION FOR ORAL ADMINISTRATION COMPRISING PROBIOTIC FORMULATION AND 5-HT4 RECEPTOR AGONIST AND METHOD FOR THE PREPARATION THEREOF | HANMI HOLDINGS CO., LTD. (KR) | 2011-09-09 | — | — | WO | claimed |
| US-20110123612-A1 | PHARMACEUTICAL PREPARATION CONTAINING NON-DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-2 RECEPTOR BLOCKER | HANALL BIOPHARMA CO., LTD (KR) | 2011-05-26 | — | — | US | claimed |
| US-20110117194-A1 | PHARMACEUTICAL FORMULATION CONTAINING ANGIOTENSIN-II RECEPTOR BLOCKER | HANALL BIOPHARMA CO., LTD. (KR) | 2011-05-19 | — | — | US | claimed |
| US-20110111022-A1 | PHARMACEUTICAL FORMULATION | HANALL BIOPHARMA CO., LTD. (KR) | 2011-05-12 | — | — | US | claimed |
| US-20110111021-A1 | PHARMACEUTICAL PREPARATION | HANALL BIOPHARMA CO., LTD. (KR) | 2011-05-12 | — | — | US | claimed |
| US-20110052683-A1 | PHARMACEUTICAL PREPARATION FOR TREATING CARDIOVASCULAR DISEASE | HANALL BIOPHARMA CO., LTD. (KR) | 2011-03-03 | — | — | US | claimed |
| US-20110038931-A1 | COMPOSITE PREPARATION | HANALL BIOPHARMA CO., LTD. (KR) | 2011-02-17 | — | — | US | claimed |
| EP-2281557-A2 | PHARMACEUTICAL FORMULATION CONTAINING ANGIOTENSIN-II RECEPTOR BLOCKER | HanAll Biopharma Co., Ltd. (KR) | 2011-02-09 | — | — | EP | claimed |
| EP-2275093-A2 | PHARMACEUTICAL FORMULATION | HanAll Biopharma Co., Ltd. (KR) | 2011-01-19 | — | — | EP | claimed |
| EP-2255797-A2 | COMPOSITE PREPARATION | HanAll Biopharma Co., Ltd. (KR) | 2010-12-01 | — | — | EP | claimed |
| EP-2255796-A2 | PHARMACEUTICAL PREPARATION | HanAll Biopharma Co., Ltd. (KR) | 2010-12-01 | — | — | EP | claimed |
| EP-2180891-A2 | COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME | Hanall Pharmaceutical Co., Ltd. (KR) | 2010-05-05 | — | — | EP | claimed |
| WO-2009022821-A2 | COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME | HANALL PHARMACEUTICAL COMPANY. LTD (KR) | 2009-02-19 | — | — | WO | claimed |
| WO-2023128710-A1 | TABLET CONTAINING MIXED EXTRACT OF CINNAMOMI RAMULUS AND MOUTAN RADICIS CORTEX AS ACTIVE INGREDIENT AND COMPOSITION DESIGNED TO ADMINISTER SPECIFIC DOSAGE THEREOF FOR TREATMENT | 주식회사 큐라클 | 2023-07-06 | — | — | WO | disclosed |
| EP-2180891-A2 | COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME | Hanall Pharmaceutical Co., Ltd. (KR) | 2010-05-05 | — | — | EP | disclosed |
| WO-2009022821-A2 | COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME | HANALL PHARMACEUTICAL COMPANY. LTD (KR) | 2009-02-19 | — | — | WO | disclosed |